Here are three ENTs who recently moved to new practices:
Uncategorized
The ASC market valuation is expected to surpass $42 billion by 2027, up from $16 billion in 2020, according to a report from research and management consulting firm Global Market Insights.
Here are 10 more gastroenterologists to know:
Here are five key updates from ENT companies and practices over the past two months:
Inpatient and outpatient surgical volume for ENT procedures in the U.S. dropped at the start of the COVID-19 pandemic last year, but saw a relatively quick rebound, according to research published in JAMA Otolaryngology - Head & Neck Surgery.
The American Otological Society and the American Neurotology Society's publishing arm launched an open-access journal, Otology & Neurotology Open.
Franklin (Tenn.) Surgery Center, a United Surgical Partners International affiliate, is the first ASC in Tennessee to perform an Inspire Therapy procedure, a treatment for sleep apnea, in the ambulatory setting.
ASC administrators have been working diligently to manage the day-to-day operations of ASCs amid the COVID-19 pandemic.
ENT and Allergy Associates, based in Tarrytown, N.Y., signed a three-year contract extension with Cigna.
Boston-based Mass Eye and Ear named Michael Gilmore, PhD, its first chief scientific officer.
